PAIN
Volume 149, Issue 2 , Pages 273-277 , May 2010

Relationships among alexithymia and pain intensity, pain interference, and vitality in persons with neuromuscular disease: Considering the effect of negative affectivity

  • Masako Hosoi

      Affiliations

    • Department of Psychosomatic Medicine, Kyushu University Hospital, 3-1-1 Maidashi, Higashiku, Fukuoka 812-8582, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 92 642 5320; fax: +81 92 642 5336.
  • ,
  • Ivan R. Molton

      Affiliations

    • Department of Rehabilitation Medicine, University of Washington School of Medicine, Box 356490, Seattle, WA, USA
  • ,
  • Mark P. Jensen

      Affiliations

    • Department of Rehabilitation Medicine, University of Washington School of Medicine, Box 356490, Seattle, WA, USA
  • ,
  • Dawn M. Ehde

      Affiliations

    • Department of Rehabilitation Medicine, University of Washington School of Medicine, Box 356490, Seattle, WA, USA
  • ,
  • Silvia Amtmann

      Affiliations

    • Department of Rehabilitation Medicine, University of Washington School of Medicine, Box 356490, Seattle, WA, USA
  • ,
  • Sarah O’Brien

      Affiliations

    • Department of Rehabilitation Medicine, University of Washington School of Medicine, Box 356490, Seattle, WA, USA
  • ,
  • Tatsuyuki Arimura

      Affiliations

    • Department of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka 812-8582, Japan
  • ,
  • Chiharu Kubo

      Affiliations

    • Department of Psychosomatic Medicine, Kyushu University Hospital, 3-1-1 Maidashi, Higashiku, Fukuoka 812-8582, Japan

Received 1 October 2008 ,Revised 28 January 2010 ,Accepted 8 February 2010.

References 

  1. Ahlberg J, Nikkila H, Kononen M, Partinen M, Lindholm H, Sarna S, et al. Associations of perceived pain and painless TMD-related symptoms with alexithymia and depressive mood in media personnel with or without irregular shift work. Acta Odontol Scand. 2004;62:119–123
  2. Antonini G, Soscia F, Giubilei F, De Carolis A, Gragnani F, Morino S, et al. Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med. 2006;38:181–185
  3. Bach M, Bach D. Predictive value of alexithymia: a prospective study in somatizing patients. Psychother Psychosom. 1995;64:43–48
  4. Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale – I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38:23–32
  5. Bagby RM, Taylor GJ, Parker JD. The twenty-item Toronto Alexithymia Scale – II. Convergent, discriminant, and concurrent validity. J Psychosom Res. 1994;38:33–40
  6. Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations. J Pers Soc Psychol. 1986;51:1173–1182
  7. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129–138
  8. Cleland C, Magura S, Foote J, Rosenblum A, Kosanke N. Psychometric properties of the Toronto Alexithymia Scale (TAS-20) for substance users. J Psychosom Res. 2005;58:299–306
  9. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983;17:197–210
  10. De Gucht V, Heiser W. Alexithymia and somatisation: quantitative review of the literature. J Psychosom Res. 2003;54:425–434
  11. Glaros AG, Lumley MA. Alexithymia and pain in temporomandibular disorder. J Psychosom Res. 2005;59:85–88
  12. Hanley MA, Jensen MP, Ehde DM, Hoffman AJ, Patterson DR, Robinson LR. Psychosocial predictors of long-term adjustment to lower-limb amputation and phantom limb pain. Disabil Rehabil. 2004;26:882–893
  13. Haviland MG, Shaw DG, MacMurray JP, Cummings MA. Validation of the Toronto Alexithymia Scale with substance abusers. Psychother Psychosom. 1988;50:81–87
  14. Haviland MG, Warren WL, Riggs ML, Nitch SR. Concurrent validity of two observer-rated alexithymia measures. Psychosomatics. 2002;43:472–477
  15. Huber A, Suman AL, Biasi G, Carli G. Alexithymia in fibromyalgia syndrome: associations with ongoing pain, experimental pain sensitivity and illness behavior. J Psychosom Res. 2009;66:425–433
  16. Jensen MP. The neurophysiology of pain perception and hypnotic analgesia: implications for clinical practice. Am J Clin Hypnos. 2008;51:123–148
  17. Jensen MP, Hoffman AJ, Stoelb BL, Abresch RT, Carter GT, McDonald CM. Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy. Arch Phys Med Rehabil. 2008;89:320–328
  18. Kano M, Hamaguchi T, Itoh M, Yanai K, Fukudo S. Correlation between alexithymia and hypersensitivity to visceral stimulation in human. Pain. 2007;132:252–263
  19. Kosturek A, Gregory RJ, Sousou AJ, Trief P. Alexithymia and somatic amplification in chronic pain. Psychosomatics. 1998;39:399–404
  20. Lane RD, Lee S, Reidel R, Weldon V, Kaszniak A, Schwartz G. Impaired verbal and nonverbal emotion recognition in alexithymia. Psychosom Med. 1996;58:203–210
  21. Levant RF. Desperately seeking language: understanding, assessing, and treating normative male alexithymia. In:  Brooks GR,  Good GE editor. The new handbook of psychotherapy and counseling with men: a comprehensive guide to settings, problems, and treatment approaches. San Francisco, CA: Jossey-Bass/Pfeiffer; 2001;p. 424–443
  22. Linden W, Wen F, Paulhus DL. Measuring alexithymia: reliability, validity, and prevalence. Adv Pers Assess. 1995;10:51–95
  23. Loas G, Seillier A, Freville C. Psychoaffective immaturity in psychiatric disorders. Psychol Rep. 2001;88:111–114
  24. Lumley MA, Radcliffe AM, Macklem DJ, Mosley-Williams A, Leisen JC, Huffman JL, et al. Alexithymia and pain in three chronic pain samples: comparing Caucasians and African Americans. Pain Med. 2005;6:251–261
  25. Lumley MA, Smith JA, Longo DJ. The relationship of alexithymia to pain severity and impairment among patients with chronic myofascial pain: comparisons with self-efficacy, catastrophizing, and depression. J Psychosom Res. 2002;53:823–830
  26. Madioni F, Mammana LA. Toronto Alexithymia Scale in outpatients with sexual disorders. Psychopathology. 2001;34:95–98
  27. Mattila AK, Kronholm E, Jula A, Salminen JK, Koivisto AM, Mielonen R, et al. Alexithymia and somatization in general population. Psychosom Med. 2008;70:716–722
  28. Mehling WE, Krause N. Alexithymia and 7.5-year incidence of compensated low back pain in 1207 urban public transit operators. J Psychosom Res. 2007;62:667–674
  29. Parker JD, Taylor GJ, Bagby RM. Alexithymia and the recognition of facial expressions of emotion. Psychother Psychosom. 1993;59:197–202
  30. Porcelli P, Tulipani C, Maiello E, Cilenti G, Todarello O. Alexithymia, coping, and illness behavior correlates of pain experience in cancer patients. Psychooncology. 2007;16:644–650
  31. Saarijarvi S, Salminen JK, Toikka T. Temporal stability of alexithymia over a five-year period in outpatients with major depression. Psychother Psychosom. 2006;75:107–112
  32. Sayar K, Gulec H, Topbas M. Alexithymia and anger in patients with fibromyalgia. Clin Rheumatol. 2004;23:441–448
  33. Sifneous PE. The prevalence of ‘alexithymic’ characteristics in psychosomatic patients. Psychother Psychosom. 1973;22:255–262
  34. Taylor GJ, Bagby RM, Parker JDA. Disorders of affect regulation. Cambridge, UK: Cambridge University Press; 1997;
  35. Taylor GJ, Ryan D, Bagby RM. Toward the development of a new self-report alexithymia scale. Psychother Psychosom. 1985;44:191–199
  36. Tiffreau V, Viet G, Thevenon A. Pain and neuromuscular disease: the results of a survey. Am J Phys Med Rehabil. 2006;85:756–766
  37. Tyler EJ, Jensen MP, Engel JM, Schwartz L. The reliability and validity of pain interference measures in persons with cerebral palsy. Arch Phys Med Rehabil. 2002;83:236–239
  38. Ware JE. SF-36 health survey update. Spine. 2000;25:3130–3139

PII: S0304-3959(10)00087-4

doi: 10.1016/j.pain.2010.02.012

PAIN
Volume 149, Issue 2 , Pages 273-277 , May 2010